SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-399662
Filing Date
2014-11-06
Accepted
2014-11-06 07:00:52
Documents
3
Period of Report
2014-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d818062d8k.htm 8-K 15315
2 EX-99.1 d818062dex991.htm EX-99.1 54867
3 GRAPHIC g818062g90c38.jpg GRAPHIC 3802
  Complete submission text file 0001193125-14-399662.txt   77047
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 141198734
SIC: 3841 Surgical & Medical Instruments & Apparatus